Surrozen IND Cleared for SZN-8141; Trials Funded
Surrozen announced FDA clearance of its Investigational New Drug (IND) application for SZN-8141. The company expects a $95.1 million second closing to fund upcoming trials.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.